Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
FAQs
Jasper Therapeutics (JSPR) Stock Forecast, Price Targets and Analysts Predictions - TipRanks.com? ›
The average price target for Jasper Therapeutics is $67.50. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $80.00 ,the lowest forecast is $55.00. The average price target represents 190.82% Increase from the current price of $23.21.
What is the target price for JSPR? ›| Ticker | Price | Price Target |
|---|---|---|
| JSPR | $29.08 | $68.75 |
| OCS | $11.99 | $30.75 |
| CDMO | $6.90 | $12.25 |
| CBUS | $18.25 | $25.00 |
Jasper Therapeutics Stock Forecast
The 7 analysts with 12-month price forecasts for Jasper Therapeutics stock have an average target of 64.79, with a low estimate of 40 and a high estimate of 80. The average target predicts an increase of 200.09% from the current stock price of 21.59.
| High | $10.00 |
|---|---|
| Median | $7.00 |
| Low | $4.75 |
| Average | $7.22 |
| Current Price | $3.52 |
AI Stock 12 Month Forecast
Based on 13 Wall Street analysts offering 12 month price targets for C3ai in the last 3 months. The average price target is $30.55 with a high forecast of $40.00 and a low forecast of $20.00.
Jasper Therapeutics's analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts. How can I buy shares of JSPR?
Is Jasper AI a public company? ›Jasper AI is a privately held company and therefore does not have a public stock price. However, you may access Jasper AI's private market stock price with Forge Data.
What is the stock forecast for JSPR in 2030? ›Stock Prediction 2030. In 2030, the Jasper Therapeutics, Inc. stock will reach $ 2.75 if it maintains its current 10-year average growth rate. If this Jasper Therapeutics, Inc. stock prediction for 2030 materializes, JSPR stock will grow -90.09% from its current price.
What is the stock price forecast for Stoneco in 2025? ›On average, Wall Street analysts predict that Stoneco's share price could reach $19.00 by Apr 2, 2025. The average Stoneco stock price prediction forecasts a potential upside of 24.59% from the current STNE share price of $15.25.
What is Kal stock price forecast for 2025? ›Kalera Public Limited Company stock prediction for 1 year from now: $ 1.120000 (0.00%) Kalera Public Limited Company stock forecast for 2025: $ 0.750716 (-32.97%) Kalera Public Limited Company stock prediction for 2030: $ 0.101570 (-90.93%)
Is an increase in stock price good? ›
In general, strong earnings generally result in the stock price moving up (and vice versa). But some companies that are not making that much money still have a rocketing stock price. This rising price reflects investor expectations that the company will be profitable in the future.
Why is well stock going up? ›The high-growth company has seen more and more growth in the telemedicine and digital health space over the years, which already is a rapidly growing industry. Analysts in fact predict that strong revenue growth will continue for WELL stock for years to come.
Who is the most accurate stock prediction? ›1. AltIndex – Overall Most Accurate Stock Predictor with Claimed 72% Win Rate. From our research, AltIndex is the most accurate stock predictor to consider today. Unlike other predictor services, AltIndex doesn't rely on manual research or analysis.
What is the most accurate stock prediction algorithm? ›The LSTM algorithm has the ability to store historical information and is widely used in stock price prediction (Heaton et al. 2016). For stock price prediction, LSTM network performance has been greatly appreciated when combined with NLP, which uses news text data as input to predict price trends.
What are the best AI ETFS to invest in? ›| ETF | Assets under management | Expense ratio |
|---|---|---|
| Roundhill Generative AI & Technology ETF (CHAT) | $138 million | 0.75% |
| Amplify AI Powered Equity ETF (AIEQ) | $107 million | 0.75% |
| iShares Robotics and Artificial Intelligence Multisector ETF (IRBO) | $661 million | 0.47% |
Also, in 2025, WELL Health is expected to post EPS of $0.17 (up from $0.11), and in 2026 expectations are calling for EPS of $0.40 (up from $0.24). In conclusion, for those investors who are willing and able to put up with the volatility, I would definitely say that WELL stock is a buy.
What does well stock mean? ›well-stocked in British English
adjective (well stocked when postpositive) having or containing sufficient goods, wares, food, etc. Collins English Dictionary.
Instrument Name Well Health Technologies Corp (WELL-T)
No future dividend declared.
WELL Health Technologies Corp Financial Overview
WELL Health Technologies Corp's market cap is currently ―. The company's EPS TTM is C$-0.002; its P/E ratio is -1,353.85; WELL Health Technologies Corp is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is C$0.06.